{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:41:54Z","timestamp":1757313714531,"version":"3.40.4"},"reference-count":14,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>A 75-year-old man presented to our hospital with multifocal thickening of the left pleura and left pleural effusion. Histology of the pleura showed uniform and bipolar spindle cells with moderate mitosis in a collagenised stroma. It further showed abundant blood vessels in a haemangiopericytoma-like pattern. These findings were strongly suggestive of malignant solitary fibrous tumour (SFT). The tumour showed negative staining for CD34. The loss of CD34 expression could imply histologically high-grade tumour, as reported previously. Imatinib, a multityrosine kinase inhibitor with targets, including platelet-derived growth factor receptor (PDGFR)-\u03b1 and PDGFR-\u03b2, has antitumour activity in some patients with SFT. Unfortunately, imatinib treatment failed to control disease progression in the present case that expressed PDGFR-\u03b2, but not PDGFR-\u03b1. This report described a case of CD34-negative SFT resistant to imatinib.<\/jats:p>","DOI":"10.1136\/bcr-2013-200126","type":"journal-article","created":{"date-parts":[[2013,7,6]],"date-time":"2013-07-06T07:03:13Z","timestamp":1373094193000},"page":"bcr2013200126","source":"Crossref","is-referenced-by-count":3,"title":["CD34-negative solitary fibrous tumour resistant to imatinib"],"prefix":"10.1136","volume":"2013","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3575-1384","authenticated-orcid":false,"given":"Koichiro","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Otsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryotaro","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0199-6378","authenticated-orcid":false,"given":"Kuniaki","family":"Shirao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0003-4975(01)03374-4","article-title":"Solitary fibrous tumors of the pleura","volume":"2013","author":"De Perrot","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0046-8177(95)90147-7","article-title":"Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites","volume":"2013","author":"Hanau","year":"1995","journal-title":"Hum Pathol"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0046-8177(95)90145-0","article-title":"CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma","volume":"2013","author":"Flint","year":"1995","journal-title":"Hum Pathol"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/modpathol.3800248","article-title":"Distinction of endometrial stromal sarcomas from \u201chemangiopericytomatous\u201d tumors using a panel of immunohistochemical stains","volume":"2013","author":"Bhargava","year":"2005","journal-title":"Mod Pathol"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2559.1998.00412.x","article-title":"Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation","volume":"2013","author":"Yokoi","year":"1998","journal-title":"Histopathol"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.6","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00268-008-9604-y","article-title":"Solitary fibrous tumor of the pleura: an analysis of 13 cases","volume":"2013","author":"Lu","year":"2008","journal-title":"World J Surg"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"2013","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.8","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","article-title":"Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study","volume":"2013","author":"Sawyers","year":"2002","journal-title":"Blood"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2013","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.2005.07.088","article-title":"Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: imatinib target exploration consortium study B2225","volume":"2013","author":"McArthur","year":"2005","journal-title":"J Clin Oncol"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/PAI.0b013e318198f23e","article-title":"Malignant solitary fibrous tumor: report of 3 cases with unusual features","volume":"2013","author":"Hu","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5858\/2004-128-460-RSFTOT","article-title":"Recurrent solitary fibrous tumor of the pleura with malignant transformation","volume":"2013","author":"Kanthan","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.13","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/JTO.0b013e3181803f08","article-title":"Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura","volume":"2013","author":"De Pas","year":"2008","journal-title":"J Thorac Oncol"},{"key":"2025042708310219000_2013.jul05_1.bcr2013200126.14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1378\/chest.130.2.581","article-title":"Pleural malignant solitary fibrous tumor with sarcomatous overgrowth showing PDGFRbeta mutation","volume":"2013","author":"Rossi","year":"2006","journal-title":"Chest"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-200126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T15:31:11Z","timestamp":1745767871000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-200126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":14,"alternative-id":["10.1136\/bcr-2013-200126"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-200126","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}